Algo version: 0.98b
Sinopep-Allsino Bio is listed at the SHH Exchange
Sinopep-Allsino Bio [688076.SS]
SHH Sector: Healthcare Industry:Biotechnology

Is Sinopep-Allsino Bio stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Sinopep-Allsino Bio pays dividends. Last time was Tuesday 10th of September 2024 where the investors holding the stock on Tuesday 10th of September 2024 were paid CNY0.1 per share. Over the last 4 times between 2022 and 2024, Sinopep-Allsino Bio has paid CNY0.85 with an average of CNY0.21 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sinopep-Allsino Bio 10 years ago, but if you had invested on Thursday 20th of May 2021 when the price was CNY77.50, you would have made a loss of CNY-18.28 per share or -23.59%

Yes, the average daily trading liquidity for Sinopep-Allsino Bio is CNY4.22 million. You should therefore be able to get in and out of your positions relatively fast.

Sinopep-Allsino Bio has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.25, the company's ability to pay off the debt is normal. Sinopep-Allsino Bio has a good net profit margin of 17.68% and should have high tolerances against inflation.

We have calculated the inflation risk for Sinopep-Allsino Bio to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.